Christopher Lau

2.9k total citations · 2 hit papers
24 papers, 1.7k citations indexed

About

Christopher Lau is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Christopher Lau has authored 24 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Oncology. Recurrent topics in Christopher Lau's work include Radiomics and Machine Learning in Medical Imaging (4 papers), Advanced X-ray and CT Imaging (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Christopher Lau is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (4 papers), Advanced X-ray and CT Imaging (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Christopher Lau collaborates with scholars based in United States, Austria and Mexico. Christopher Lau's co-authors include Marc Ladanyi, Maria E. Arcila, Maureen F. Zakowski, Mark G. Kris, Khédoudja Nafa, Jamie E. Chaft, Paul K. Paik, Natasha Rekhtman, Boris Reva and Sinchita Roy‐Chowdhuri and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and The Journal of Urology.

In The Last Decade

Christopher Lau

23 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence, Clinicopathologic Associations, and Molecular Spectrum of ERBB2 ( HER2 ) Tyrosine Kinase Mutations in Lung Adenocarcinomas

2012 366 citations Maria E. Arcila, Jamie E. Chaft et al. Clinical Cancer Research profile →
EGFR Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics

2013 348 citations Maria E. Arcila, Khédoudja Nafa et al. Molecular Cancer Therapeutics profile →

Peers

Countries citing papers authored by Christopher Lau

Since Specialization

Citations

This map shows the geographic impact of Christopher Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Lau more than expected).

Fields of papers citing papers by Christopher Lau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Lau. The network helps show where Christopher Lau may publish in the future.

Co-authorship network of co-authors of Christopher Lau

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Lau. A scholar is included among the top collaborators of Christopher Lau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Lau. Christopher Lau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Shape and texture-based radiomics signature on CT effectively discriminates benign from malignant renal masses 2020 ·European Radiology ·Felix Y. Yap, Bino Varghese, Steven Cen, Darryl Hwang, Xiaomeng Lei, Bhushan Desai, Christopher Lau, (unknown), (unknown), (unknown), (unknown), (unknown), Brian D. Quinn, Manju Aron, Mihir Desai, Monish Aron, Assad A. Oberai, Inderbir S. Gill, Vinay Duddalwar	54
2	An Imaging Stewardship Initiative to Reduce Low-Value Positron Emission Tomography-Computed Tomography Use in Hospitalized Patients 2020 ·Journal for Healthcare Quality ·Richard Eliáš, Deanne T. Kashiwagi, Christopher Lau, Stephanie L. Hansel	2
3	Deep learning based classification of solid lipid-poor contrast enhancing renal masses using contrast enhanced CT 2020 ·British Journal of Radiology ·Assad A. Oberai, Bino Varghese, Steven Cen, (unknown), Darryl Hwang, Inderbir S. Gill, Manju Aron, Christopher Lau, Vinay Duddalwar	31
4	Reliability of CT‐based texture features: Phantom study 2019 ·Journal of Applied Clinical Medical Physics ·Bino Varghese, Darryl Hwang, Steven Cen, Joshua Levy, Derek Liu, Christopher Lau, (unknown), Bhushan Desai, David J. Goodenough, Vinay Duddalwar	54
5	EGFR Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics breakdown → 2013 ·Molecular Cancer Therapeutics ·Maria E. Arcila, Khédoudja Nafa, Jamie E. Chaft, Natasha Rekhtman, Christopher Lau, Boris Reva, Maureen F. Zakowski, Mark G. Kris, Marc Ladanyi	348
6	Prevalence, Clinicopathologic Associations, and Molecular Spectrum of ERBB2 ( HER2 ) Tyrosine Kinase Mutations in Lung Adenocarcinomas breakdown → 2012 ·Clinical Cancer Research ·Maria E. Arcila, Jamie E. Chaft, Khédoudja Nafa, Sinchita Roy‐Chowdhuri, Christopher Lau, Michael Zaidinski, Paul K. Paik, Maureen F. Zakowski, Mark G. Kris, Marc Ladanyi	366
7	Coexistence of PIK3CA and Other Oncogene Mutations in Lung Adenocarcinoma–Rationale for Comprehensive Mutation Profiling 2011 ·Molecular Cancer Therapeutics ·Jamie E. Chaft, Maria E. Arcila, Paul K. Paik, Christopher Lau, Gregory J. Riely, M. Catherine Pietanza, Maureen F. Zakowski, Valerie W. Rusch, Camelia S. Sima, Marc Ladanyi, Mark G. Kris	162
8	Detection of KRAS and BRAF Mutations in Colorectal Carcinoma 2011 ·Journal of Molecular Diagnostics ·Maria E. Arcila, Christopher Lau, Khédoudja Nafa, Marc Ladanyi	109
9	Primary Lung Adenocarcinomas in Children and Adolescents Treated for Pediatric Malignancies 2010 ·Journal of Thoracic Oncology ·Mark L. Kayton, Mai He, Maureen F. Zakowski, (unknown), Christopher Lau, Alexander J. Chou, Melinda S. Merchant, Pamela R. Merola, Leonard H. Wexler, Michael P. LaQuaglia, William D. Travis, Marc Ladanyi	15
10	Frequency of EGFR and KRAS Mutations in Lung Adenocarcinomas in African Americans 2010 ·Journal of Thoracic Oncology ·J. Matthew Reinersman, Melissa L. Johnson, Gregory J. Riely, Dhananjay Chitale, Anthony D. Nicastri, Gerald A. Soff, Ann G. Schwartz, Camelia S. Sima, (unknown), Christopher Lau, Maureen F. Zakowski, Valerie W. Rusch, Marc Ladanyi, Mark G. Kris	112
11	Comprehensive Genomic Analysis Reveals Clinically Relevant Molecular Distinctions between Thymic Carcinomas and Thymomas 2009 ·Clinical Cancer Research ·Nicolas Girard, Ronglai Shen, Tianhua Guo, Maureen F. Zakowski, Adriana Heguy, Gregory J. Riely, James Huang, Christopher Lau, Alex Lash, Marc Ladanyi, Agnès Viale, Cristina R. Antonescu, William D. Travis, Valerie W. Rusch, Mark G. Kris, William Pao	147
12	The development of a prediction tool for chemotherapy-induced anemia in patients with advanced non-small cell lung cancer (NSCLC) palliative receiving chemotherapy 2006 ·Journal of Clinical Oncology ·Mark Vincent, George Dranitsaris, (unknown), Siddharth Verma, Christopher Lau, Pere Gascón, Sebastian Belle, (unknown)	1
13	Application and Evaluation of Personal Health Information Management System 2005 ·PubMed ·Eung-Hun Kim, (unknown), Christopher Lau, Yong‐Min Kim	24
14	Image quality budget for the Generation-X Telescope 2005 ·Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE ·Jonathan W. Arenberg, Christopher Lau, Amy Lo	0
15	Advanced PET/CT fusion workstation for oncology imaging 2005 ·Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE ·Christopher Lau, Dev S. Pathak, Lixin Gong, Paul E. Kinahan, Phillip M. Cheng, Lydia Ng	2
16	Personal Health Information Management System and its Application in Referral Management 2004 ·IEEE Transactions on Information Technology in Biomedicine ·Maggie Haitian Wang, Christopher Lau, Frederick A. Matsen, (unknown)	61
17	Asynchronous web-based patient-centered home telemedicine system 2002 ·IEEE Transactions on Biomedical Engineering ·Christopher Lau, R. Sean Churchill, Jung Kim, F A Matsen, (unknown)	53
18	<title>Web-based home telemedicine system for orthopedics</title> 2001 ·Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE ·Christopher Lau, (unknown), Janice Kim, F. A. Matsen, Yong-Min Kim	3
19	<title>MPEG-4 coding of ultrasound sequences</title> 2000 ·Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE ·Christopher Lau, (unknown), (unknown), Yongmin Kim	2
20	Non-invasive image acquisition and advanced processing in optical bioimaging 1998 ·Computerized Medical Imaging and Graphics ·Daniel L. Farkas, Congwu Du, Gregory W. Fisher, Christopher Lau, (unknown), E. S. Wachman, Richard M. Levenson	85

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact